Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma?

HPB

Volumn 10, Issue 2, 2008, Pages 98-105

  Buc, E ^a   Lesurtel, M ^a   Belghiti, J ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNE PANCREATITIS; BILE DUCT CARCINOMA; BILE DUCT DILATATION; BILE DUCT DISEASE; BILE DUCT OBSTRUCTION; BILIARY TRACT SURGERY; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL FEATURE; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MIRIZZI SYNDROME; PATIENT REFERRAL; PREOPERATIVE EVALUATION; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; TUMOR BIOPSY;

EID: 46649106098     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820802014585     Document Type: Review

References (92)

1. DeOliveira, ML, Cunningham, SC, Cameron, JL, Kamangar, F., Winter, JM Lillemoe, KD et al. (2007) Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution. Ann Surg, 245, pp. 755-762.
2. Shaib, Y. and El-Serag, HB. (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis, 24, pp. 115-125.
3. Khan, SA, Thomas, HC, Davidson, BR and Taylor-Robinson, SD. (2005) Cholangiocarcinoma. Lancet, 366, pp. 1303-1314.
4. Are, C., Gonen, M., D'Angelica, M., DeMatteo, RP, Fong, Y. Blumgart, LH et al. (2006) Differential diagnosis of proximal biliary obstruction. Surgery, 140, pp. 756-763.
5. Binkley, CE, Eckhauser, FE and Colletti, LM. (2002) Unusual causes of benign biliary strictures with cholangiographic features of cholangiocarcinoma. J Gastrointest Surg, 6, pp. 676-681.
6. Corvera, CU, Blumgart, LH, Darvishian, F., Klimstra, DS, DeMatteo, R. Fong, Y. et al. (2005) Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg, 201, pp. 862-869.
7. Gerhards, MF, Vos, P., van Gulik, TM, Rauws, EA, Bosma, A. and Gouma, DJ. (2001) Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg, 88, pp. 48-51.
8. Hadjis, NS, Collier, NA and Blumgart, LH. (1985) Malignant masquerade at the hilum of the liver. Br J Surg, 72, pp. 659-661.
9. Koea, J., Holden, A., Chau, K. and McCall, J. (2004) Differential diagnosis of stenosing lesions at the hepatic hilus. World J Surg, 28, pp. 466-470.
10. Nakayama, A., Imamura, H., Shimada, R., Miyagawa, S., Makuuchi, M. and Kawasaki, S. (1999) Proximal bile duct stricture disguised as malignant neoplasm. Surgery, 125, pp. 514-521.
11. Standfield, NJ, Salisbury, JR and Howard, ER. (1989) Benign non-traumatic inflammatory strictures of the extrahepatic biliary system. Br J Surg, 76, pp. 849-852.
12. Verbeek, PC, van Leeuwen, DJ, de Wit, LT, Reeders, JW, Smits, NJ Bosma, A. et al. (1992) Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery, 112, pp. 866-871.
13. Wetter, LA, Ring, EJ, Pellegrini, CA and Way, LW (1991) Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg, 161, pp. 57-62.
14. Knoefel, WT, Prenzel, KL, Peiper, M., Hosch, SB, Gundlach, M. Eisenberger, CF et al. (2003) Klatskin tumors and Klatskin mimicking lesions of the biliary tree. Eur J Surg Oncol, 29, pp. 658-661.
15. Warshaw, AL (1991) Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg, 161, pp. 26-29.
16. de Bellis, M., Sherman, S., Fogel, EL, Cramer, H., Chappo, J. McHenry Jr, L. et al. (2002) Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc, 56, pp. 720-730.
17. Foutch, PG, Kerr, DM, Harlan, JR and Kummet, TD. (1991) A prospective, controlled analysis of endoscopic cytotechniques for diagnosis of malignant biliary strictures. Am J Gastroenterol, 86, pp. 577-580.
18. Glasbrenner, B., Ardan, M., Boeck, W., Preclik, G., Moller, P. and Adler, G. (1999) Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy, 31, pp. 712-717.
19. Harewood, GC, Baron, TH, Stadheim, LM, Kipp, BR, Sebo, TJ and Salomao, DR. (2004) Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am J Gastroenterol, 99, pp. 1464-1469.
20. Jailwala, J., Fogel, EL, Sherman, S., Gottlieb, K., Flueckiger, J. Bucksot, LG et al. (2000) Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc, 51, pp. 383-390.
21. Lee, JG, Leung, JW, Baillie, J., Layfield, LJ and Cotton, PB. (1995) Benign, dysplastic, or malignant-making sense of endoscopic bile duct brush cytology: Results in 149 consecutive patients. Am J Gastroenterol, 90, pp. 722-726.
22. Macken, E., Drijkoningen, M., Van Aken, E. and Van Steenbergen, W. (2000) Brush cytology of ductal strictures during ERCP. Acta Gastroenterol Belg, 63, pp. 254-259.
23. Mansfield, JC, Griffin, SM, Wadehra, V. and Matthewson, K. (1997) A prospective evaluation of cytology from biliary strictures. Gut, 40, pp. 671-677.
24. Ponchon, T., Gagnon, P., Berger, F., Labadie, M., Liaras, A. Chavaillon, A. et al. (1995) Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: Results of a prospective study. Gastrointest Endosc, 42, pp. 565-572.
25. Pugliese, V., Conio, M., Nicolo, G., Saccomanno, S. and Gatteschi, B. (1995) Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: A prospective study. Gastrointest Endosc, 42, pp. 520-526.
26. Stewart, CJ, Mills, PR, Carter, R., O'Donohue, J., Fullarton, G. Imrie, CW et al. (2001) Brush cytology in the assessment of pancreatico-biliary strictures: A review of 406 cases. J Clin Pathol, 54, pp. 449-455.
27. Logrono, R., Kurtycz, DF, Molina, CP, Trivedi, VA, Wong, JY and Block, KP. (2000) Analysis of false-negative diagnoses on endoscopic brush cytology of biliary and pancreatic duct strictures: The experience at two university hospitals. Arch Pathol Lab Med, 124, pp. 387-392.
28. Mohandas, KM, Swaroop, VS, Gullar, SU, Dave, UR, Jagannath, P. and DeSouza, LJ. (1994) Diagnosis of malignant obstructive jaundice by bile cytology: Results improved by dilating the bile duct strictures. Gastrointest Endosc, 40, pp. 150-154.
29. Parasher, VK and Huibregtse, K. (1998) Endoscopic retrograde wire-guided cytology of malignant biliary strictures using a novel scraping brush. Gastrointest Endosc, 48, pp. 288-290.
30. de Bellis, M., Fogel, EL, Sherman, S., Watkins, JL, Chappo, J. Younger, C. et al. (2003) Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointest Endosc, 58, pp. 176-182.
31. Howell, DA, Parsons, WG, Jones, MA, Bosco, JJ and Hanson, BL. (1996) Complete tissue sampling of biliary strictures at ERCP using a new device. Gastrointest Endosc, 43, pp. 498-502.
32. Wiersema, MJ, Hawes, RH, Tao, LC, Wiersema, LM, Kopecky, KK Rex, DK et al. (1992) Endoscopic ultrasonography as an adjunct to fine needle aspiration cytology of the upper and lower gastrointestinal tract. Gastrointest Endosc, 38, pp. 35-39.
33. Andriulli, A., Loperfido, S., Napolitano, G., Niro, G., Valvano, MR Spirito, F. et al. (2007) Incidence rates of post-ERCP complications: A systematic survey of prospective studies. Am J Gastroenterol, 102, pp. 1781-1788.
34. Fogel, EL, deBellis, M., McHenry, L., Watkins, JL, Chappo, J. Cramer, H. et al. (2006) Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: A prospective study. Gastrointest Endosc, 63, pp. 71-77.
35. Eloubeidi, MA, Chen, VK, Jhala, NC, Eltoum, IE, Jhala, D. Chhieng, DC et al. (2004) Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol, 2, pp. 209-213.
36. Fritscher-Ravens, A., Broering, DC, Sriram, PV, Topalidis, T., Jaeckle, S. Thonke, F. et al. (2000) EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: A case series. Gastrointest Endosc, 52, pp. 534-540.
37. Rosch, T., Hofrichter, K., Frimberger, E., Meining, A., Born, P. Weigert, N. et al. (2004) ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest Endosc, 60, pp. 390-396.
38. Blumgart, LH (2006) Surgery of the liver, biliary tract, and pancreas.
39. Chijiiwa, K., Kimura, H. and Tanaka, M. (1995) Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction. The difference in risk between patients with and without choledochal cyst. Int Surg, 80, pp. 61-64.
40. Hawkins, WG, DeMatteo, RP, Jarnagin, WR, Ben-Porat, L., Blumgart, LH and Fong, Y. (2004) Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol, 11, pp. 310-315.
41. Warshaw, AL and Welch, JP. (1978) Extrahepatic biliary obstruction by metastatic colon carcinoma. Ann Surg, 188, pp. 593-597.
42. Takasan, H., Kitamura, O., Ozawa, K. and Honjo, I. (1973) Metastatic cancer of the liver resulting in obstruction of the extrahepatic bile duct. Am J Surg, 125, pp. 782-785.
43. Maroy, B., Moullot, P., Daloubeix, H., Lavaud, H. and Lancret, C. (1988) Intraductal biliary metastasis of a colonic cancer. Ann Radiol, 31, pp. 309-311.
44. Bower, TC and Nagorney, DM (1988) Mirizzi syndrome. HPB Surg, 1, pp. 67-74.
45. Hunt, DR. (2004) Another paper on Mirizzi Syndrome?. ANZ J Surg, 74, p. 826.
46. Becker, CD, Grossholz, M., Mentha, G., de Peyer, R. and Terrier, F. (1997) MR cholangiopancreatography: Technique, potential indications, and diagnostic features of benign, postoperative, and malignant conditions. Eur Radiol, 7, pp. 865-874.
47. Fulcher, AS, Turner, MA and Capps, GW (1999) MR cholangiography: technical advances and clinical applications. Radiographics, 19, pp. 25-41.
48. Soto, JA, Yucel, EK, Barish, MA, Chuttani, R. and Ferrucci, JT. (1996) MR cholangiopancreatography after unsuccessful or incomplete ERCP. Radiology, 199, pp. 91-98.
49. Broome, U., Olsson, R., Loof, L., Bodemar, G., Hultcrantz, R. Danielsson, A. et al. (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut, 38, pp. 610-615.
50. LaRusso, NF, Shneider, BL, Black, D., Gores, GJ, James, SP Doo, E. et al. (2006) Primary sclerosing cholangitis: Summary of a workshop. Hepatology, 44, pp. 746-764.
51. Rea, DJ, Heimbach, JK, Rosen, CB, Haddock, MG, Alberts, SR Kremers, WK et al. (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg, 242, pp. 451-458.
52. Levy, C., Lymp, J., Angulo, P., Gores, GJ, Larusso, N. and Lindor, KD. (2005) The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci, 50, pp. 1734-1740.
53. Nichols, JC, Gores, GJ, LaRusso, NF, Wiesner, RH, Nagorney, DM and Ritts Jr, RE (1993) Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc, 68, pp. 874-879.
54. Furmanczyk, PS, Grieco, VS and Agoff, SN. (2005) Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: Evaluation of specific cytomorphologic features and CA19-9 levels. Am J Clin Pathol, 124, pp. 355-360.
55. Horiuchi, R., Uchida, T., Kojima, T. and Shikata, T. (1990) Inflammatory pseudotumor of the liver. Clinicopathologic study and review of the literature. Cancer, 65, pp. 1583-1590.
56. Amankonah, TD, Strom, CB, Vierling, JM and Petrovic, LM. (2001) Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease. Am J Gastroenterol, 96, pp. 2520-2522.
57. Jafri, SZ, Bree, RL, Agha, FP and Schwab, RE. (1983) Inflammatory pseudotumor from sclerosing cholangitis. J Comput Assist Tomogr, 7, pp. 902-904.
58. Nakanuma, Y., Tsuneyama, K., Masuda, S. and Tomioka, T. (1994) Hepatic inflammatory pseudotumor associated with chronic cholangitis: Report of three cases. Hum Pathol, 25, pp. 86-91.
59. Nonomura, A., Minato, H., Shimizu, K., Kadoya, M. and Matsui, O. (1997) Hepatic hilar inflammatory pseudotumor mimicking cholangiocarcinoma with cholangitis and phlebitis-a variant of primary sclerosing cholangitis?. Pathol Res Pract, 193, pp. 519-525.
60. Hayashi, K., Nakazawa, T., Ohara, H., Ando, T., Takada, H. Tanaka, H. et al. (2007) Autoimmune sclerosing cholangiopancreatitis with little pancreatic involvements by imaging findings. Hepatogastroenterology, 54, pp. 2146-2151.
61. Hochwald, SN, Hemming, AW, Draganov, P., Vogel, SB, Dixon, LR and Grobmyer, SR (2008) Elevation of serum IgG4 in Western patients with autoimmune sclerosing pancreatocholangitis: A word of caution. Ann Surg Oncol
62. Kawaguchi, K., Koike, M., Tsuruta, K., Okamoto, A., Tabata, I. and Fujita, N. (1991) Lymphoplasmacytic sclerosing pancreatitis with cholangitis: A variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol, 22, pp. 387-395.
63. Kawamoto, S., Siegelman, SS, Hruban, RH and Fishman, EK. (2008) Lymphoplasmacytic sclerosing pancreatitis (autoimmune pancreatitis): evaluation with multidetector CT. Radiographics, 28, pp. 157-170.
64. Erkelens, GW, Vleggaar, FP, Lesterhuis, W., van Buuren, HR and van der Werf, SD. (1999) Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet, 354, pp. 43-44.
65. Margulis, SJ, Honig, CL, Soave, R., Govoni, AF, Mouradian, JA and Jacobson, IM. (1986) Biliary tract obstruction in the acquired immunodeficiency syndrome. Ann Intern Med, 105, pp. 207-210.
66. Abdalian, R. and Heathcote, EJ. (2006) Sclerosing cholangitis: A focus on secondary causes. Hepatology, 44, pp. 1063-1074.
67. Akaki, S., Kobayashi, H., Sasai, N., Tsunoda, M., Kuroda, M. Kanazawa, S. et al. (2002) Bile duct stenosis due to portal cavernomas: MR portography and MR cholangiopancreatography demonstration. Abdom Imaging, 27, pp. 58-60.
68. Chandra, R., Kapoor, D., Tharakan, A., Chaudhary, A. and Sarin, SK. (2001) Portal biliopathy. J Gastroenterol Hepatol, 16, pp. 1086-1092.
69. Dhiman, RK, Puri, P., Chawla, Y., Minz, M., Bapuraj, JR Gupta, S. et al. (1999) Biliary changes in extrahepatic portal venous obstruction: compression by collaterals or ischemic?. Gastrointest Endosc, 50, pp. 646-652.
70. Sarin, SK, Bhatia, V. and Makwana, U. (1992) Portal biliopathy in extrahepatic portal venous obstruction. Indian J Gastroenterol, 11, p. A82.
71. Shin, SM, Kim, S., Lee, JW, Kim, CW, Lee, TH Lee, SH et al. (2007) Biliary abnormalities associated with portal biliopathy: Evaluation on MR cholangiography. Am J Roentgenol, 188, p. W341.
72. Khuroo, MS, Yattoo, GN, Zargar, SA, Javid, G., Dar, MY Khan, BA et al. (1993) Biliary abnormalities associated with extrahepatic portal venous obstruction. Hepatology, 17, pp. 807-813.
73. Gibson, JB, Johnston, GW, Fulton, TT and Rodgers, HW. (1965) Extrahepatic portal-venous obstruction. Br J Surg, 52, pp. 129-139.
74. Umphress, JL, Pecha, RE and Urayama, S. (2004) Biliary stricture caused by portal biliopathy: Diagnosis by EUS with Doppler US. Gastrointest Endosc, 60, pp. 1021-1024.
75. Kunisaki, SM, Hertl, M., Bodner, BE and Cosimi, AB. (2005) Mirizzi syndrome secondary to an adenoma of the cystic duct. J Hepatobil Pancreat Surg, 12, pp. 159-162.
76. Allaire, GS, Rabin, L., Ishak, KG and Sesterhenn, IA. (1988) Bile duct adenoma. A study of 152 cases. Am J Surg Pathol, 12, pp. 708-715.
77. Hasebe, T., Sakamoto, M., Mukai, K., Kawano, N., Konishi, M. Ryu, M. et al. (1995) Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma. Virchows Arch, 426, pp. 209-213.
78. Cattell, RB, Braasch, JW and Kahn, F. (1962) Polypoid epithelial tumors of the bile ducts. N Engl J Med, 266, pp. 57-61.
79. Dowdy Jr, GS, Olin Jr, WG, Shelton Jr, EL and Waldron, GW. (1962) Benign tumors of the extrahepatic bile ducts. Report of three cases and review of the literature. Arch Surg, 85, pp. 503-513.
80. Kawakatsu, M., Vilgrain, V., Zins, M., Vullierme, M., Belghiti, J. and Menu, Y. (1997) Radiologic features of papillary adenoma and papillomatosis of the biliary tract. Abdom Imaging, 22, pp. 87-90.
81. Buckley, JG and Salimi, Z. (1993) Villous adenoma of the common bile duct. Abdom Imaging, 18, pp. 245-246.
82. Choi, BI, Lee, JM and Han, JK. (2004) Imaging of intrahepatic and hilar cholangiocarcinoma. Abdom Imaging, 29, pp. 548-557.
83. Khan, SA, Davidson, BR, Goldin, R., Pereira, SP, Rosenberg, WM Taylor-Robinson, SD et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: Consensus document. Gut, 51, pp. 1-9.
84. Mousseau, M., Schaerer, R., Lutz, JM, Menegoz, F., Faure, H. and Swiercz, P. (1991) Hepatic metastasis of unknown primary site. Bull Cancer, 78, pp. 725-736.
85. Pouessel, D., Thezenas, S., Culine, S., Becht, C., Senesse, P. and Ychou, M. (2005) Hepatic metastases from carcinomas of unknown primary site. Gastroenterol Clin Biol, 29, pp. 1224-1232.
86. Hainsworth, JD and Greco, FA. (1993) Treatment of patients with cancer of an unknown primary site. N Engl J Med, 329, pp. 257-263.
87. Culine, S., Kramar, A., Saghatchian, M., Bugat, R., Lesimple, T. Lortholary, A. et al. (2002) Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol, 20, pp. 4679-4683.
88. Sporn, JR and Greenberg, BR. (1993) Empirical chemotherapy for adenocarcinoma of unknown primary tumor site. Semin Oncol, 20, pp. 261-267.
89. Verhoef, C., Kuiken, BW, JN, IJ and de Wilt, JH. (2007) Partial hepatic resection for liver metastases of non-colorectal origin, is it justified?. Hepatogastroenterology, 54, pp. 1517-1521.
90. Hawksworth, J., Geisinger, K., Zagoria, R., Kavanagh, P., Howerton, R. Levine, EA et al. (2004) Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor. Am Surg, 70, pp. 512-517.
91. Schneider, BJ, El-Rayes, B., Muler, JH, Philip, PA, Kalemkerian, GP Griffith, KA et al. (2007) Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site. Cancer, 110, pp. 770-775.
92. Blendis, L. and Halpern, Z. (2004) An increasing incidence of cholangiocarcinoma: Why?. Gastroenterology, 127, pp. 1008-1009.